🇺🇸 FDA

Drug profile · INN

asparaginase

GRASPA

approved L01XX02
US status
approved
Patents linked
6
News articles
0

Quick answer

asparaginase (GRASPA) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.

Key facts

INN asparaginase
Brand GRASPA
Formulation VIAL
ATC code L01XX02

Related patents

Search patents →

  1. US 12121571

    Recombinant L-asparaginase

    Expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11802279

    Modified L-asparaginase

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11578315

    Truncated guinea pig L-asparaginase variants and methods of use

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11046946

    PEGylated L-asparaginase

    Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10174302

    Modified L-asparaginase

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9920311

    PEGylated L-asparaginase

    Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is asparaginase?

asparaginase (GRASPA) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.

What is the brand name for asparaginase?

GRASPA is a marketed brand name for asparaginase. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of asparaginase?

asparaginase has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.